Dr. Goldberg is the Director of the Division of Endocrinology. Diabetes and Metabolism at New York University Langone School of Medicine and the Clarissa and Edgar Bronfman Professor of Medicine. His clinical practice focuses on disorders of lipids metabolism seeing patients with elevated circulating levels of triglycerides, cholesterol, and Lp(a). In addition, he has been a clinical investigator in trials using new methods to lower circulating triglyceride levels to prevent pancreatitis. Dr. Goldberg graduated from MIT, received his medical degree from Harvard Medical School, and served his internship and residency in medicine at New York University-Bellevue Hospital Medical Center. He subsequently completed fellowships in endocrinology and metabolism and atherosclerosis and metabolism, at Mount Sinai School of Medicine in New York City. Prior to his arrival at NYU in 2014, he was at Columbia University where he served as Chief of the Division of Preventive Medicine and Nutrition and the Dickinson Richards Professor of Medicine. Dr. Goldberg has published over 300 articles. These include written numerous book chapters, editorials, and reviews. He has co-authored chapters on lipid disorders in the 14th and 15th editions of Harrison’s Principles of Internal Medicine and the current edition of Williams Textbook of Endocrinology. Dr. Goldberg’s research funded by the NIH and American Heart Association (AHA) has focused on abnormalities of lipoprotein metabolism, macrovascular disease in diabetes, and the role of triglycerides in atherosclerosis. Among Dr. Goldberg’s honors is a MERIT Award from the National Heart, Lung, and Blood Institute and a number of named lectureships including R. Levy and and Lyman Duff Lectures (AHA), and E. Bierman Lecture on diabetes and heart disease (American Diabetes Association.